Did you know there’s even more we can do to promote your episode? Find out more…
Pep Gubau, CEOm, CTO & Co-Founder at Aizon talks about the role that AI plays in the pharma manufacturing industry.
Our host Raman Sehgal talks about the big headwinds for the pharmaceutical and biotechnology space for 2026.
Our host discusses with three senior leaders on their insights from The JPM’s Annual Healthcare Conference 2026.
Our host Raman Sehgal summarises predictions from CDMO C-suite leaders for the pharmaceutical and biotechnology space for 2026.
Selin Kurnaz, Co-Founder & CEO of Massive Bio talks about the role of AI in drug development and her entrepreneurial journey.
Jim Gale, Founding Partner & Managing Director at Signet Healthcare Partners discusses the importance and impact of private equity.
Here is our host, Raman Sehgal’s top 5 Molecule to Market episodes of 2025.
Dr Thomas Dobmeyer, ekwithree talks about his medical career, his experience in niche regulatory affairs and investment.
M2M’s 250th episode! Our host Raman Sehgal summarises the highlights from the 2025 guest interviews and provides key insights for 2026.
Nick Fortin, CEO of Codis talks about his leadership in transforming Particle Dynamis into Codis and managing multiple stakeholders.
